# Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)

> **NCT06331884** · PHASE1 · COMPLETED · sponsor: **4TEEN4 Pharmaceuticals GmbH** · enrollment: 24 (actual)

## Conditions studied

- Safety and Tolerability
- Healthy Volunteers

## Interventions

- **DRUG:** AK1967 (Procizumab)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06331884
- **Lead sponsor:** 4TEEN4 Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-07
- **Primary completion:** 2024-08-05
- **Final completion:** 2024-09-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06331884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06331884, "Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06331884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*